Q9NRG4 (SMYD2_HUMAN) Homo sapiens (Human)
N-lysine methyltransferase SMYD2 UniProtKBInterProSTRINGInteractive Modelling
433 aa; Sequence (Fasta) ; (Isoform 2)
It is possible new templates exist for this target since these models were created.
Available Structures
22 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Structural Basis of Estrogen Receptor Alpha Methylation Mediated by Histone Methyltransferase SmyD2 |
Heteromer P03372; | 3×ZN; 1×SAH; 1×PE8; 2×NI; | ||||
| Assess | ||||||
| Structure of SMYD2 in complex with p53 and SAH |
Heteromer P04637; | 1×GOL; 1×SAH; 3×ZN; | ||||
| Assess | ||||||
| Crystal structure of SMYD2 with SAM and EPZ033294 | monomer | 1×SAM; 3×ZN; 2×8WG; 2×PEG; 1×EDO; 2×GOL; | ||||
| Assess | ||||||
| SET and MYND Domain Containing protein 2 | monomer | 3×ZN; 1×A4M; 1×DMS; 1×TRS; 5×UNX; | ||||
| Assess | ||||||
| Crystal structure of histone lysine methyltransferase SmyD2 in complex with polyethylene glycol | monomer | 1×SAH; 1×12P; 2×NI; 5×EOH; 3×ZN; | ||||
| Assess | ||||||
| Crystal Structure of Protein Lysine Methyltransferase SMYD2 in complex with LLY-507, a Cell-Active,… | monomer | 1×3UJ; 1×SAH; 3×GOL; 4×ZN; | ||||
| Assess | ||||||
| SMYD2 in complex with AZ370 | monomer | 1×SAM; 4×BU3; 1×6T1; 3×ZN; | ||||
| Assess | ||||||
| SMYD2 in complex with AZ931 | monomer | 1×SAM; 1×6TM; 3×ZN; | ||||
| Assess | ||||||
| Structural Basis of Substrate Methylation and Inhibition of SMYD2 | monomer | 1×SAH; 3×BU3; 3×ZN; | ||||
| Assess | ||||||
| Structural Basis of Substrate Methylation and Inhibition of SMYD2 | monomer | 1×SAM; 5×BU3; 1×NH5; 3×ZN; | ||||
| Assess | ||||||
| Crystal structure of human SMYD2 in complex with Nle-peptide inhibitor | monomer | 3×ZN; 1×SAH; 1×GOL; | ||||
| Assess | ||||||
| SMYD2 in complex with AZ506 | monomer | 1×SAM; 6×BU3; 2×NA; 1×6TL; 3×ZN; | ||||
| Assess | ||||||
| Structural Basis of Substrate Methylation and Inhibition of SMYD2 | monomer | 1×SAM; 1×BU3; 3×ZN; | ||||
| Assess | ||||||
| Crystal structure of human SET and MYND Domain Containing protein 2 with MTF1497 | monomer | 3×ZN; 1×EW1; 1×CL; 2×EDO; 5×UNX; | ||||
| Assess | ||||||
| Crystal structure of human SET and MYND Domain Containing protein 2 with MTF9975 | monomer | 3×ZN; 1×EW4; | ||||
| Assess | ||||||
| SMYD2 in complex with AZ378 | monomer | 1×SAM; 3×ZN; | ||||
| Assess | ||||||
| The Discovery of A-893, A New Cell-Active Benzoxazinone Inhibitor of Lysine Methyltransferase SMYD2 | monomer | 3×ZN; 1×4GQ; 1×SAM; | ||||
| Assess | ||||||
| Structural Basis of Substrate Methylation and Inhibition of SMYD2 | monomer | 1×SAM; 3×ZN; | ||||
| Assess | ||||||
| Structure of SMYD2 in complex with SAM | monomer | 1×SAM; 3×ZN; 5×GOL; | ||||
| Assess | ||||||
| Human lysine methyltransferase Smyd2 in complex with AdoHcy | monomer | 3×ZN; 1×SAH; 7×SO4; | ||||
| Assess | ||||||
| SMYD2 in complex with SGC probe BAY-598 | monomer | 3×ZN; 1×H41; 1×GOL; 1×SAM; | ||||
| Assess | ||||||
| SMYD2 in complex with small molecule inhibitor compound-2 | monomer | 1×I9H; 1×SAM; 3×ZN; | ||||
| Assess | ||||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 3s7d.1.A | monomer | 0.91 | 1×BU3; 3×ZN; | 99.77 | ||
| Assess | ||||||
1 SWISS-MODEL model built on isoform sequence
| Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 2 | 3s7d.1.A | monomer | 0.93 | 1×BU3; 3×ZN; | 99.63 | |
| Assess | ||||||